The Diagnosis and Management of Non-alcoholic
nature publishing group
PRACTICE GUIDELINES
811
The Diagnosis and Management of Non-alcoholic
Fatty Liver Disease: Practice Guideline by the
American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
12345Naga Chalasani , MD, FACG , Zobair Younossi , MD, FACG , Joel E. Lavine , MD, PhD , Anna Mae Diehl , MD , Elizabeth M. Brunt , MD ,
678
Kenneth Cusi , MD , Michael Charlton , MD and Arun J. Sanyal , MD
Am J Gastroenterol2012; 107: 811 –826; doi: 10.1038/ajg.2012.128; published online 29 May 2012 Preamble De nitions
ese recommendations are based on the following: (i) a formal Th
review and analysis of the recently published world literature on the topic (Medline search up to June 2011); (ii) the Ameri-can College of Physicians ’ Manual for Assessing Health Practices and Designing Practice Guidelines; ( 1 ) (iii) guideline policies of the three societies approving this document; and (iv) the experi-ence of the authors and independent reviewers with regards to non-alcoholic fatty liver disease (NAFLD).
Intended for use by physicians and allied health profession-
als, these recommendations suggest preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. Th ey are intended to be fl exible and adjustable for individual patients. Spe-cifi c recommendations are evidence based wherever possible, and when such evidence is not available or inconsistent, recommenda-tions are made based on the consensus opinion of the authors. To best characterize the evidence cited in support of the recommen-dations, the AASLD Practice Guidelines Committee has adopted the classifi cation used by the GRADE (Grading of Recommenda-tion Assessment, Development, and Evaluation) workgroup with minor modifi cations ( Table 1)( 2). Th e strength of recommenda-tions in the GRADE system is classifi ed as strong (1) or weak (2). Th e quality of evidence supporting strong or weak recommenda-tions is designated by one of three levels: high (A), moderate (B), or low quality (C) ( 2 ). Th is is a practice guideline for clinicians rather than a review article and interested readers can refer to several comprehensive reviews published recently ( 3 – 8 ).
1
e defiTh nition of NAFLD requires that (i) there is evidence of
hepatic steatosis, either by imaging or by histology and (ii) there are no causes for secondary hepatic fat accumulation such as sig-nifi cant alcohol consumption, use of steatogenic medication, or hereditary disorders ( Table 2 ). In the majority of patients, NAFLD is associated with metabolic risk factors such as obesity, diabetes mellitus, and dyslipidemia. NAFLD is histologically further cat-egorized into non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) ( Table 3 ). NAFL is defi ned as the presence of hepatic steatosis with no evidence of hepatocellular injury in the form of ballooning of the hepatocytes. NASH is defi ned as the presence of hepatic steatosis and infl ammation with hepatocyte injury (ballooning) with or without fibrosis. Incidence and prevalence in the general population
e incidence of NAFLD has been investigated in a limited number Th
of studies. Two Japanese studies ( 9,10 ) reported an incidence rate of 31 and 86 cases of suspected NAFLD per 1,000 person-years, respectively, whereas another study from England showed a much lower incidence rate of 29 cases per 100,000 person-years ( 11 ). More studies are needed to better understand the incidence of NAFLD across diff erent age, ethnic, and geographic groups. Th e reported prevalence of NAFLD varies widely depending on the population studied and the defi nition used. Th e prevalence of histologically defi ned NAFLD was 20 and 51 % in two diff er-ent studies comprised of potential living liver donors ( 12,13 ).
2
Indiana University School of Medicine , Indianapolis , Indiana , USA ; Department of Medicine, Center for Liver Disease, InovaFairfax Hospital , New York , New
345
York , USA ; Falls Church Columbia University , New York , New York , USA ; Duke University , Durham , North Carolina , USA ; Washington University , St Louis ,
678
Missouri , USA ; University of Florida , Gainesville , Florida , USA ; Mayo Clinic , Rochester , Minnesota , USA ; Virginia Commonwealth University , Richmond , Virginia , USA . Correspondence: Naga Chalasani, MD, FACG , Medicine and Cellular and Integrative Physiology, Director, Division of Gastroenterology & Hepatology, Indiana University School of Medicine , RG 4100, 1050 Wishard Boulevard, Indianapolis , Indiana 46202 , USA . E-mail: nchalasa@iupui.edu Submitted for Governing Board approval by AASLD, ACG, and AGA on 22 February 2012.
This article is being published jointly in 2012 in Gastroenterology , American Journal of Gastroenterology , and Hepatology . Received 4 April 2012; accepted 4 April 2012
© 2012 by the American College of Gastroenterology
The American Journal of GASTROENTEROLOGY
10.1111/j.1751-2980.2010.00476.x Consensus report Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010 (Published...
The_Diagnosis_and_Management_of_Traumatic.14_电子/电路_工程科技_专业资料。TOPIC CHAPTER 10 CHAPTER 10 The Diagnosis and Management of Traumatic Atlanto-...
DIAGNOSIS AND MANAGEMENT OF ISOLATED PANCREATIC TUBERCULOSIS: EXPERIENCE OF 13... The diagnosis and trea... 11人阅读 4页 2.00 Diagnosis and Manageme...
Diagnosis and Management of Intractable Hemoptysis by Bronchoscopic Intervention_专业资料。Ap.0,lme,.SraNo6)r 0Vou7No4(eil.5 21 Jua forl -iaMeia cec,SN...
practical guidelines for diagnosis, management and prevention of the disease. ...in only about one-third of alcoholic and 6% of non alcoholic patients....
Research on the applications of infrared technique in the diagnosis and prediction of diesel eng_专业资料。Junlfhrlcec o.0No2(01)199 ora Tema ineV1,....
指南 Brief introduction of practice guideline for the diagnosis and management of non-alcoholic fatty liver disease SHEN Feng, DING Xiao-Dong, FAN Jian-...
中国消化不良诊治指南 肿瘤营养学的指南与实践 Guidelines for Colonoscopy Surveillance After Screening and Polypectomy The Diagnosis and Management of Non-alco...
1 TOP 10:美国非酒精性脂肪性肝病诊治指南 非酒精性脂肪肝病是慢性肝病的常见类型 The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice ...
Arnold G Smith MD Page 1 of 5 The Diagnosis And Treatment Of The Sacro-Iliac Joint As A Cause Of Low Back Pain — The Management Of Pain In ...
热门文档